...
首页> 外文期刊>European radiology >Tumour ADC measurements in rectal cancer: effect of ROI methods on ADC values and interobserver variability.
【24h】

Tumour ADC measurements in rectal cancer: effect of ROI methods on ADC values and interobserver variability.

机译:直肠癌的肿瘤ADC测量:ROI方法对ADC值和观察者间差异的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: To assess the influence of region of interest (ROI) size and positioning on tumour ADC measurements and interobserver variability in patients with locally advanced rectal cancer (LARC). METHODS: Forty-six LARC patients were retrospectively included. Patients underwent MRI including DWI (b0,500,1000) before and 6-8 weeks after chemoradiation (CRT). Two readers measured mean tumour ADCs (pre- and post-CRT) according to three ROI protocols: whole-volume, single-slice or small solid samples. The three protocols were compared for differences in ADC, SD and interobserver variability (measured as the intraclass correlation coefficient; ICC). RESULTS: ICC for the whole-volume ROIs was excellent (0.91) pre-CRT versus good (0.66) post-CRT. ICCs were 0.53 and 0.42 for the single-slice ROIs versus 0.60 and 0.65 for the sample ROIs. Pre-CRT ADCs for the sample ROIs were significantly lower than for the whole-volume or single-slice ROIs. Post-CRT there were no significant differences between the whole-volume ROIs and the single-slice or sample ROIs, respectively. The SDs for the whole-volume and single-slice ROIs were significantly larger than for the sample ROIs. CONCLUSIONS: ROI size and positioning have a considerable influence on tumour ADC values and interobserver variability. Interobserver variability is worse after CRT. ADCs obtained from the whole tumour volume provide the most reproducible results. Key Points * ROI size and positioning influence tumour ADC measurements in rectal cancer * ROI size and positioning influence interobserver variability of tumour ADC measurements * ADC measurements of the whole tumour volume provide the most reproducible results * Tumour ADC measurements are more reproducible before, rather than after, chemoradiation treatment * Variations caused by ROI size and positioning should be taken into account when using ADC as a biomarker for tumour response.
机译:目的:评估感兴趣区域(ROI)大小和位置对局部晚期直肠癌(LARC)患者肿瘤ADC测量值和观察者间差异的影响。方法:回顾性纳入46例LARC患者。患者在放化疗(CRT)之前和之后的6-8周接受了包括DWI(b0,500,1000)在内的MRI检查。两名读者根据三种ROI方案(整体积,单切片或小固体样品)测量了平均肿瘤ADC(CRT前后)。比较了这三种协议在ADC,SD和观察者之间的差异(以类内相关系数; ICC衡量)方面的差异。结果:CRT前的整体ROI的ICC极好(0.91),而CRT后为良好(0.66)。单切片ROI的ICC为0.53和0.42,而样本ROI的ICC为0.60和0.65。样品ROI的CRT前ADC显着低于整体或单切片ROI。 CRT后,总体积ROI和单切片或样品ROI之间没有显着差异。整体ROI和单切片ROI的SD显着大于样本ROI的SD。结论:ROI的大小和位置对肿瘤ADC值和观察者间的变异性有很大影响。 CRT后观察者间的变异性更差。从整个肿瘤体积获得的ADC提供了最可重复的结果。关键点* ROI的大小和位置影响直肠癌中肿瘤ADC的测量* ROI的大小和位置影响肿瘤ADC测量中的观察者间差异*整个肿瘤体积的ADC测量提供最可重复的结果*肿瘤ADC的测量比以前更可重复之后,进行化学放射治疗*使用ADC作为肿瘤反应的生物标志物时,应考虑到由ROI大小和位置引起的差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号